Results from a 6-month study observing BioElectronics’ ActiPatch® musculoskeletal pain therapy device indicated an average 61% reduction in pain for >90% of participants, improved quality of life, a decrease in visits to the doctor or pain specialist, etc.
Of the 254 chronic pain sufferers that participated, 224 completed the full 6-month study.
Specifically, observed results included:
- No side effects
- Treatment durability: >90% of participants reported continued relief averaging a 61% reduction in pain, even after 6 months
- Improved quality of life: 90% reported improved sleep, 89% reported greater physical activity and 71% reported quality of life as “much better” to “a great deal better”
- Decreased medication use: 86% reported a decrease in medication use that continued to improve over time, including prescription narcotic-based drugs
- Decreased adverse events from medication use: 68% were experiencing adverse side effects; of these, 71% reported a reduction in adverse side effects
- Healthcare savings: 65% spent less on pain therapies; 65% reported fewer visits to the doctor and pain specialist
The disposable, $30 ActiPatch device is an over-the-counter treatment for back pain and other musculoskeletal complaints.
Source: BioElectronics Corporation
Results from a 6-month study observing BioElectronics' ActiPatch® musculoskeletal pain therapy device indicated an average 61% reduction in pain for >90% of participants, improved quality of life, a decrease in visits to the doctor or pain specialist, etc.
Of the 254 chronic pain sufferers that participated, 224 completed the full 6-month...
Results from a 6-month study observing BioElectronics’ ActiPatch® musculoskeletal pain therapy device indicated an average 61% reduction in pain for >90% of participants, improved quality of life, a decrease in visits to the doctor or pain specialist, etc.
Of the 254 chronic pain sufferers that participated, 224 completed the full 6-month study.
Specifically, observed results included:
- No side effects
- Treatment durability: >90% of participants reported continued relief averaging a 61% reduction in pain, even after 6 months
- Improved quality of life: 90% reported improved sleep, 89% reported greater physical activity and 71% reported quality of life as “much better” to “a great deal better”
- Decreased medication use: 86% reported a decrease in medication use that continued to improve over time, including prescription narcotic-based drugs
- Decreased adverse events from medication use: 68% were experiencing adverse side effects; of these, 71% reported a reduction in adverse side effects
- Healthcare savings: 65% spent less on pain therapies; 65% reported fewer visits to the doctor and pain specialist
The disposable, $30 ActiPatch device is an over-the-counter treatment for back pain and other musculoskeletal complaints.
Source: BioElectronics Corporation
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.